The diarylquinoline TMC207 for multidrug-resistant tuberculosis.

By A. Diacon, A. Pym, M. Grobusch, R. Patientia, R. Rustomjee, L. Page-Shipp, Christoffel Pistorius, R. Krause, M. Bogoshi, G. Churchyard and 12 more. New England Journal of Medicine, 2009

786 citations recorded by the source corpus.

Subfields: Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/479e8eb03828f7540f696f54e00fb380e7d3a1b8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. O’Neill
2. I. Chopra
3. Richard E. Lee
4. J. Hurdle

Citations in the corpus

• Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections (2010, background): “Further studies to explore this observation are needed, as synergy with PZA was not reported in clinical trials with TMC207 (Ref”
• Multidrug-resistant tuberculosis and culture conversion with bedaquiline. (2014, neutral): “Fluoroquinolone resistance 6/54 (11) 4/58 (7) 10/112 (9)”